- •Contents
- •Contributors
- •Part I General Principles of Cell Death
- •1 Human Caspases – Apoptosis and Inflammation Signaling Proteases
- •1.1. Apoptosis and limited proteolysis
- •1.2. Caspase evolution
- •2. ACTIVATION MECHANISMS
- •2.2. The activation platforms
- •2.4. Proteolytic maturation
- •3. CASPASE SUBSTRATES
- •4. REGULATION BY NATURAL INHIBITORS
- •REFERENCES
- •2 Inhibitor of Apoptosis Proteins
- •2. CELLULAR FUNCTIONS AND PHENOTYPES OF IAP
- •3. IN VIVO FUNCTIONS OF IAP FAMILY PROTEINS
- •4. SUBCELLULAR LOCATIONS OF IAP
- •8. IAP–IAP INTERACTIONS
- •10. ENDOGENOUS ANTAGONISTS OF IAP
- •11. IAPs AND DISEASE
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2.1. The CD95 (Fas/APO-1) system
- •2.1.1. CD95 and CD95L: discovery of the first direct apoptosis-inducing receptor-ligand system
- •2.1.2. Biochemistry of CD95 apoptosis signaling
- •2.2. The TRAIL (Apo2L) system
- •3.1. The TNF system
- •3.1.1. Biochemistry of TNF signal transduction
- •3.1.2. TNF and TNF blockers in the clinic
- •3.2. The DR3 system
- •4. THE DR6 SYSTEM
- •6. CONCLUDING REMARKS AND OUTLOOK
- •SUGGESTED READINGS
- •4 Mitochondria and Cell Death
- •1. INTRODUCTION
- •2. MITOCHONDRIAL PHYSIOLOGY
- •3. THE MITOCHONDRIAL PATHWAY OF APOPTOSIS
- •9. CONCLUSIONS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •3. INHIBITING APOPTOSIS
- •4. INHIBITING THE INHIBITORS
- •6. THE BCL-2 FAMILY AND CANCER
- •SUGGESTED READINGS
- •6 Endoplasmic Reticulum Stress Response in Cell Death and Cell Survival
- •1. INTRODUCTION
- •2. THE ESR IN YEAST
- •3. THE ESR IN MAMMALS
- •4. THE ESR AND CELL DEATH
- •5. THE ESR IN DEVELOPMENT AND TISSUE HOMEOSTASIS
- •6. THE ESR IN HUMAN DISEASE
- •7. CONCLUSION
- •7 Autophagy – The Liaison between the Lysosomal System and Cell Death
- •1. INTRODUCTION
- •2. AUTOPHAGY
- •2.2. Physiologic functions of autophagy
- •2.3. Autophagy and human pathology
- •3. AUTOPHAGY AND CELL DEATH
- •3.1. Autophagy as anti–cell death mechanism
- •3.2. Autophagy as a cell death mechanism
- •3.3. Molecular players of the autophagy–cell death cross-talk
- •4. AUTOPHAGY, CELLULAR DEATH, AND CANCER
- •5. CONCLUDING REMARKS AND PENDING QUESTIONS
- •SUGGESTED READINGS
- •8 Cell Death in Response to Genotoxic Stress and DNA Damage
- •1. TYPES OF DNA DAMAGE AND REPAIR SYSTEMS
- •2. DNA DAMAGE RESPONSE
- •2.2. Transducers
- •2.3. Effectors
- •4. CHROMATIN MODIFICATIONS
- •5. CELL CYCLE CHECKPOINT REGULATION
- •6. WHEN REPAIR FAILS: SENESCENCE VERSUS APOPTOSIS
- •6.1. DNA damage response and the induction of apoptosis
- •6.2. p53-independent mechanisms of apoptosis
- •6.3. DNA damage response and senescence induction
- •7. DNA DAMAGE FROM OXIDATIVE STRESS
- •SUGGESTED READINGS
- •9 Ceramide and Lipid Mediators in Apoptosis
- •1. INTRODUCTION
- •3.1. Basic cell signaling often involves small molecules
- •3.2. Sphingolipids are cell-signaling molecules
- •3.2.1. Ceramide induces apoptosis
- •3.2.2. Ceramide accumulates during programmed cell death
- •3.2.3. Inhibition of ceramide production alters cell death signaling
- •4.1. Ceramide is generated through SM hydrolysis
- •4.3. aSMase can be activated independently of extracellular receptors to regulate apoptosis
- •4.4. Controversial aspects of the role of aSMase in apoptosis
- •4.5. De novo ceramide synthesis regulates programmed cell death
- •4.6. p53 and Bcl-2–like proteins are connected to de novo ceramide synthesis
- •4.7. The role and regulation of de novo synthesis in ceramide-mediated cell death is poorly understood
- •5. CONCLUDING REMARKS AND FUTURE DIRECTIONS
- •5.1. Who? (Which enzyme?)
- •5.2. What? (Which ceramide?)
- •5.3. Where? (Which compartment?)
- •5.4. When? (At what steps?)
- •5.5. How? (Through what mechanisms?)
- •5.6. What purpose?
- •6. SUMMARY
- •SUGGESTED READINGS
- •1. General Introduction
- •1.1. Cytotoxic lymphocytes and apoptosis
- •2. CYTOTOXIC GRANULES AND GRANULE EXOCYTOSIS
- •2.1. Synthesis and loading of the cytotoxic granule proteins into the secretory granules
- •2.2. The immunological synapse
- •2.3. Secretion of granule proteins
- •2.4. Uptake of proapoptotic proteins into the target cell
- •2.5. Activation of death pathways by granzymes
- •3. GRANULE-BOUND CYTOTOXIC PROTEINS
- •3.1. Perforin
- •3.2. Granulysin
- •3.3. Granzymes
- •3.3.1. GrB-mediated apoptosis
- •3.3.2. GrA-mediated cell death
- •3.3.3. Orphan granzyme-mediated cell death
- •5. CONCLUSIONS
- •REFERENCES
- •Part II Cell Death in Tissues and Organs
- •1.1. Death by trophic factor deprivation
- •1.2. Key molecules regulating neuronal apoptosis during development
- •1.2.1. Roles of caspases and Apaf-1 in neuronal cell death
- •1.2.2. Role of Bcl-2 family members in neuronal cell death
- •1.3. Signal transduction from neurotrophins and neurotrophin receptors
- •1.3.1. Signals for survival
- •1.3.2. Signals for death
- •2.1. Apoptosis in neurodegenerative diseases
- •2.1.4. Amyotrophic lateral sclerosis
- •2.2. Necrotic cell death in neurodegenerative diseases
- •2.2.1. Calpains
- •2.2.2. Cathepsins
- •3. CONCLUSIONS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •5. S-NITROSYLATION OF PARKIN
- •7. POTENTIAL TREATMENT OF EXCESSIVE NMDA-INDUCED Ca2+ INFLUX AND FREE RADICAL GENERATION
- •8. FUTURE THERAPEUTICS: NITROMEMANTINES
- •9. CONCLUSIONS
- •Acknowledgments
- •SUGGESTED READINGS
- •3. MITOCHONDRIAL PERMEABILITY TRANSITION ACTIVATED BY Ca2+ AND OXIDATIVE STRESS
- •4.1. Mitochondrial apoptotic pathways
- •4.2. Bcl-2 family proteins
- •4.3. Caspase-dependent apoptosis
- •4.4. Caspase-independent apoptosis
- •4.5. Calpains in ischemic neural cell death
- •5. SUMMARY
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. HISTORICAL ANTECEDENTS
- •7.1. Activation of p21 waf1/cip1: Targeting extrinsic and intrinsic pathways to death
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •16 Apoptosis and Homeostasis in the Eye
- •1.1. Lens
- •1.2. Retina
- •2. ROLE OF APOPTOSIS IN DISEASES OF THE EYE
- •2.1. Glaucoma
- •2.2. Age-related macular degeneration
- •4. APOPTOSIS AND OCULAR IMMUNE PRIVILEGE
- •5. CONCLUSIONS
- •SUGGESTED READINGS
- •17 Cell Death in the Inner Ear
- •3. THE COCHLEA IS THE HEARING ORGAN
- •3.1. Ototoxic hair cell death
- •3.2. Aminoglycoside-induced hair cell death
- •3.3. Cisplatin-induced hair cell death
- •3.4. Therapeutic strategies to prevent hair cell death
- •3.5. Challenges to studies of hair cell death
- •4. SPIRAL GANGLION NEURON DEATH
- •4.1. Neurotrophic support from sensory hair cells and supporting cells
- •4.2. Afferent activity from hair cells
- •4.3. Molecular manifestations of spiral ganglion neuron death
- •4.4. Therapeutic interventions to prevent SGN death
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •18 Cell Death in the Olfactory System
- •1. Introduction
- •2. Anatomical Aspects
- •3. Life and Death in the Olfactory System
- •3.1. Olfactory epithelium
- •3.2. Olfactory bulb
- •REFERENCES
- •1. Introduction
- •3.1. Beta cell death in the development of T1D
- •3.2. Mechanisms of beta cell death in type 1 diabetes
- •3.2.1. Apoptosis signaling pathways downstream of death receptors and inflammatory cytokines
- •3.2.2. Oxidative stress
- •3.3. Mechanisms of beta cell death in type 2 diabetes
- •3.3.1. Glucolipitoxicity
- •3.3.2. Endoplasmic reticulum stress
- •5. SUMMARY
- •Acknowledgments
- •REFERENCES
- •20 Apoptosis in the Physiology and Diseases of the Respiratory Tract
- •1. APOPTOSIS IN LUNG DEVELOPMENT
- •2. APOPTOSIS IN LUNG PATHOPHYSIOLOGY
- •2.1. Apoptosis in pulmonary inflammation
- •2.2. Apoptosis in acute lung injury
- •2.3. Apoptosis in chronic obstructive pulmonary disease
- •2.4. Apoptosis in interstitial lung diseases
- •2.5. Apoptosis in pulmonary arterial hypertension
- •2.6. Apoptosis in lung cancer
- •SUGGESTED READINGS
- •21 Regulation of Cell Death in the Gastrointestinal Tract
- •1. INTRODUCTION
- •2. ESOPHAGUS
- •3. STOMACH
- •4. SMALL AND LARGE INTESTINE
- •5. LIVER
- •6. PANCREAS
- •7. SUMMARY AND CONCLUDING REMARKS
- •SUGGESTED READINGS
- •22 Apoptosis in the Kidney
- •1. NORMAL KIDNEY STRUCTURE AND FUNCTION
- •3. APOPTOSIS IN ADULT KIDNEY DISEASE
- •4. REGULATION OF APOPTOSIS IN KIDNEY CELLS
- •4.1. Survival factors
- •4.2. Lethal factors
- •4.2.1. TNF superfamily cytokines
- •4.2.2. Other cytokines
- •4.2.3. Glucose
- •4.2.4. Drugs and xenobiotics
- •4.2.5. Ischemia-reperfusion and sepsis
- •5. THERAPEUTIC APPROACHES
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. APOPTOSIS IN THE NORMAL BREAST
- •2.1. Occurrence and role of apoptosis in the developing breast
- •2.2.2. Death ligands and death receptor pathway
- •2.2.4. LIF-STAT3 proapoptotic signaling
- •2.2.5. IGF survival signaling
- •2.2.6. Regulation by adhesion
- •2.2.7. PI3K/AKT pathway: molecular hub for survival signals
- •2.2.8. Downstream regulators of apoptosis: the BCL-2 family members
- •3. APOPTOSIS IN BREAST CANCER
- •3.1. Apoptosis in breast tumorigenesis and cancer progression
- •3.2. Molecular dysregulation of apoptosis in breast cancer
- •3.2.1. Altered expression of death ligands and their receptors in breast cancer
- •3.2.2. Deregulation of prosurvival growth factors and their receptors
- •3.2.3. Alterations in cell adhesion and resistance to anoikis
- •3.2.4. Enhanced activation of the PI3K/AKT pathway in breast cancer
- •3.2.5. p53 inactivation in breast cancer
- •3.2.6. Altered expression of BCL-2 family of proteins in breast cancer
- •5. CONCLUSION
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. DETECTING CELL DEATH IN THE FEMALE GONADS
- •4. APOPTOSIS AND FEMALE REPRODUCTIVE AGING
- •6. CONCLUDING REMARKS
- •REFERENCES
- •25 Apoptotic Signaling in Male Germ Cells
- •1. INTRODUCTION
- •3.1. Murine models
- •3.2. Primate models
- •3.3. Pathways of caspase activation and apoptosis
- •3.4. Apoptotic signaling in male germ cells
- •5. P38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) AND NITRIC OXIDE (NO)–MEDIATED INTRINSIC PATHWAY SIGNALING CONSTITUTES A CRITICAL COMPONENT OF APOPTOTIC SIGNALING IN MALE GERM CELLS AFTER HORMONE DEPRIVATION
- •11. CONCLUSIONS AND PERSPECTIVES
- •REFERENCES
- •26 Cell Death in the Cardiovascular System
- •1. INTRODUCTION
- •2. CELL DEATH IN THE VASCULATURE
- •2.1. Apoptosis in the developing blood vessels
- •2.2. Apoptosis in atherosclerosis
- •2.2.1. Vascular smooth muscle cells
- •2.2.2. Macrophages
- •2.2.3. Regulation of apoptosis in atherosclerosis
- •2.2.4. Necrosis and autophagy in atherosclerosis
- •3. CELL DEATH IN THE MYOCARDIUM
- •3.1. Cell death in myocardial infarction
- •3.1.1. Apoptosis in myocardial infarction
- •3.1.2. Necrosis in myocardial infarction
- •3.1.3. Autophagy in myocardial infarction
- •3.2. Cell death in heart failure
- •3.2.1. Apoptosis in heart failure
- •3.2.2. Necrosis in heart failure
- •3.2.3. Autophagy in heart failure
- •4. CONCLUDING REMARKS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •27 Cell Death Regulation in Muscle
- •1. INTRODUCTION TO MUSCLE
- •1.1. Skeletal muscle adaptation to endurance training
- •1.2. Myonuclear domains
- •2. MITOCHONDRIALLY MEDIATED APOPTOSIS IN MUSCLE
- •2.1. Skeletal muscle apoptotic susceptibility
- •4. APOPTOSIS IN MUSCLE DURING AGING AND DISEASE
- •4.1. Aging
- •4.2. Type 2 diabetes mellitus
- •4.3. Cancer cachexia
- •4.4. Chronic heart failure
- •6. CONCLUSION
- •SUGGESTED READINGS
- •28 Cell Death in the Skin
- •1. INTRODUCTION
- •2. CELL DEATH IN SKIN HOMEOSTASIS
- •2.1. Cornification and apoptosis
- •2.2. Death receptors in the skin
- •3. CELL DEATH IN SKIN PATHOLOGY
- •3.1. Sunburn
- •3.2. Skin cancer
- •3.3. Necrolysis
- •3.4. Pemphigus
- •3.5. Eczema
- •3.6. Graft-versus-host disease
- •4. CONCLUDING REMARKS AND PERSPECTIVES
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •29 Apoptosis and Cell Survival in the Immune System
- •2.1. Survival of early hematopoietic progenitors
- •2.2. Sizing of the T-cell population
- •2.2.1. Establishing central tolerance
- •2.2.2. Peripheral tolerance
- •2.2.3. Memory T cells
- •2.3. Control of apoptosis in B-cell development
- •2.3.1. Early B-cell development
- •2.3.2. Deletion of autoreactive B cells
- •2.3.3. Survival and death of activated B cells
- •3. IMPAIRED APOPTOSIS AND LEUKEMOGENESIS
- •4. CONCLUSIONS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •30 Cell Death Regulation in the Hematopoietic System
- •1. INTRODUCTION
- •2. HEMATOPOIETIC STEM CELLS
- •4. ERYTHROPOIESIS
- •5. MEGAKARYOPOIESIS
- •6. GRANULOPOIESIS
- •7. MONOPOIESIS
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •31 Apoptotic Cell Death in Sepsis
- •1. INTRODUCTION
- •2. HOST INFLAMMATORY RESPONSE TO SEPSIS
- •3. CLINICAL OBSERVATIONS OF CELL DEATH IN SEPSIS
- •3.1. Sepsis-induced apoptosis
- •3.2. Necrotic cell death in sepsis
- •4.1. Central role of apoptosis in sepsis mortality: immune effector cells and gut epithelium
- •4.2. Apoptotic pathways in sepsis-induced immune cell death
- •4.3. Investigations implicating the extrinsic apoptotic pathway in sepsis
- •4.4. Investigations implicating the intrinsic apoptotic pathway in sepsis
- •5. THE EFFECT OF APOPTOSIS ON THE IMMUNE SYSTEM
- •5.1. Cellular effects of an increased apoptotic burdens
- •5.2. Network effects of selective loss of immune cell types
- •5.3. Studies of immunomodulation by apoptotic cells in other fields
- •7. CONCLUSION
- •REFERENCES
- •32 Host–Pathogen Interactions
- •1. INTRODUCTION
- •2. FROM THE PATHOGEN PERSPECTIVE
- •2.1. Commensals versus pathogens
- •2.2. Pathogen strategies to infect the host
- •3. HOST DEFENSE
- •3.1. Antimicrobial peptides
- •3.2. PRRs and inflammation
- •3.2.1. TLRs
- •3.2.2. NLRs
- •3.2.3. The Nod signalosome
- •3.2.4. The inflammasome
- •3.3. Cell death
- •3.3.1. Apoptosis and pathogen clearance
- •3.3.2. Pyroptosis
- •3.2.3. Caspase-independent cell death
- •3.2.4. Autophagy and autophagic cell death
- •4. CONCLUSIONS
- •REFERENCES
- •Part III Cell Death in Nonmammalian Organisms
- •1. PHENOTYPE AND ASSAYS OF YEAST APOPTOSIS
- •2.1. Pheromone-induced cell death
- •2.1.1. Colony growth
- •2.1.2. Killer-induced cell death
- •3. EXTERNAL STIMULI THAT INDUCE APOPTOSIS IN YEAST
- •4. THE GENETICS OF YEAST APOPTOSIS
- •5. PROGRAMMED AND ALTRUISTIC AGING
- •SUGGESTED READINGS
- •34 Caenorhabditis elegans and Apoptosis
- •1. Overview
- •2. KILLING
- •3. SPECIFICATION
- •4. EXECUTION
- •4.1. DNA degradation
- •4.2. Mitochondrial elimination
- •4.3. Engulfment
- •5. SUMMARY
- •SUGGESTED READINGS
- •35 Apoptotic Cell Death in Drosophila
- •2. DROSOPHILA CASPASES AND PROXIMAL REGULATORS
- •6. CLOSING COMMENTS
- •SUGGESTED READINGS
- •36 Analysis of Cell Death in Zebrafish
- •1. INTRODUCTION
- •2. WHY USE ZEBRAFISH TO STUDY CELL DEATH?
- •2.2. Molecular techniques to rapidly assess gene function in embryos
- •2.2.1. Studies of gene function using microinjections into early embryos
- •2.2.2. In situ hybridization and immunohistochemistry
- •2.3. Forward genetic screening
- •2.4. Drug and small-molecule screening
- •2.5. Transgenesis
- •2.6. Targeted knockouts
- •3.1. Intrinsic apoptosis
- •3.2. Extrinsic apoptosis
- •3.3. Chk-1 suppressed apoptosis
- •3.4. Anoikis
- •3.5. Autophagy
- •3.6. Necrosis
- •4. DEVELOPMENTAL CELL DEATH IN ZEBRAFISH EMBRYOS
- •5. THE P53 PATHWAY
- •6. PERSPECTIVES AND FUTURE DIRECTIONS
- •SUGGESTED READING
AUTOPHAGY – THE LIAISON BETWEEN THE LYSOSOMAL SYSTEM AND CELL DEATH |
67 |
|||
findings, autophagy is considered to be |
|
|
|
|
cytoprotective against neurodegenera- |
|
|
|
|
tion. |
|
|
|
|
Recent studies in conditional knock- |
|
|
|
|
out mice with impaired autophagy in |
|
|
|
|
the pancreas have also revealed a critical |
|
|
|
|
role for basal macroautophagy in the |
|
|
|
|
homeostasis of beta cells, those res- |
|
|
|
|
ponsible for insulin secretion. These |
|
|
|
|
findings, along with the failure of |
|
|
|
|
autophagy to remove altered secretory |
|
|
|
|
proteins such as insulin in diabetes |
|
|
|
|
patients, have strengthened the links |
|
|
|
|
between autophagy dysfunction and |
|
|
|
|
metabolic disorders. |
|
|
|
|
Interestingly, in the four condi- |
|
|
|
|
tional mouse models with impaired |
|
|
|
|
autophagy in specific tissues devel- |
|
|
|
|
oped so far (within neurons, cardiomy- |
|
|
|
|
ocytes, hepatocytes, and beta cells of |
|
|
|
|
the pancreas), the alterations in cel- |
Figure 7-5. The dual role of autophagy as a cell defense and cell death mechanism. Left: |
|||
lular homeostasis resulting from the |
||||
Activation of autophagy protects cells against the damage caused by di erent types of stres- |
||||
autophagic failure inevitably lead to |
sors. Right: Caspases and autophagy are involved in complementary death pathways. Extra- |
|||
cellular degeneration and cell death by |
cellular death ligands such as tumor necrosis factor (TNF) activate caspases that directly or |
|||
through the involvement of mitochondria initiate apoptotic cell death. Death receptors also |
||||
apoptosis. |
||||
induce the release of active cathepsins from the lysosomal compartment. These cathepsins |
||||
|
||||
The first connection between al- |
cleave Bid, which can then trigger cathepsin-mediated mitochondria outer membrane per- |
|||
tered autophagy and disease was actu- |
meabilization (MOMP), inducing apoptotic cell death. If caspase-8 is inhibited, inhibition of |
|||
RIP by caspase-8 is released and autophagic pathway is activated through JNK pathway and |
||||
ally made with cancer, as impaired |
||||
activation of Atg proteins, leading to autophagic cell death, although the precise mecha- |
||||
autophagy was identified as a common |
||||
nisms are not clear (see text). Unregulated exacerbation of autophagy or targeted removal |
||||
feature mammary and ovary cancers. |
of antiapoptotic factors may contribute to the detrimental e ects of autophagic activation |
|||
Because the role of autophagy in car- |
under these conditions. |
|
||
|
|
|
||
cinogenesis lies directly in the inter- |
|
|
|
|
play between autophagy and cell death, we address it in |
port of and against autophagy as a cell death effector |
|||
more detail in the following sections. |
|
(Figure 7-5, right). |
|
|
3. AUTOPHAGY AND CELL DEATH |
|
3.1. Autophagy as anti–cell death mechanism |
|
As described in the introduction, the involvement of autophagy in programmed cell death has been controversial. As expected from a stress-adaptation pathway that should promote cell survival, there is profuse evidence that disruption of autophagy or of the lysosomal system promotes cell death. Evidence in support of this prosurvival role of autophagy is discussed in the first part of this section (Figure 7-5, left). However, recent studies have also proposed that excessive or deregulated autophagy can lead to both apoptotic and nonapoptotic cellular death. This process is different from the described activation of apoptosis due to lysosomal enzyme leakage, which can initiate mitochondrial permeabilization and caspase activation. In the second part of this section, we discuss the arguments in sup-
Abundant evidence supports a cytoprotective function for autophagy in very diverse cellular settings and conditions (summarized in Table 7-1). As described in the previous section, genetic blockage of autophagy by deletion of essential autophagic genes in specific tissues in the mouse causes accumulation of polyubiquitylated protein aggregates, major alterations in cellular organelles, and cellular degeneration, thus arguing that a constitutive, low level of basal autophagy in normal tissues has an essential housekeeping function.
The prosurvival effect of autophagy encompasses the two major functions of this pathway, that of acting as an alternative source of energy and as a means for removal of altered cellular components (Figure 7-4). The
68
Table 7-1. Summary of work for and against autophagic cell death
Species |
Treatment |
Effect on autophagy |
Tissue/ cell type |
Role of autophagy |
|
|
|
|
|
Autophagy as a prosurvival mechanism |
|
|
|
|
Saccharomyces cerevisiae |
ATG gene mutants and starvation |
Decrease |
|
Adaptation to starvation |
Caenorhabditis elegans |
RNAi: unc-51, bec-1, atg7, atg8, atg16, |
Decrease |
|
Early/larval development |
|
bec-1, atg8, atg18 |
|
|
|
Drosophila |
RNAi: atg1, atg3 |
Decrease |
|
Larval/pupal development |
Mouse |
RNAi: Atg5, Atg7 |
Decrease |
Brain |
Accumulation of polyubiquitylated |
|
|
|
|
proteins/degeneration |
|
Atg5 (RNAi) |
Decrease |
T and B cells (peritoneum) |
T-cell survival/proliferation B-cell development |
|
Interleukin-3 withdrawal |
Increase |
Bax–/–Bak–/– cell |
Maintenance of cellular ATP Degradation of |
|
|
|
|
glucose transporter |
|
Over-expressed bec-1 virus infection |
Decrease |
brain |
Protection against virus-induced encephalitis |
Human |
Starvation |
Increase |
HeLa cells |
Adaptation to starvation |
|
Oxidative stress |
Increase |
Several |
Damaged mitochondria removal |
|
mTOR inhibitors |
Increase |
Several |
Cell growth/proliferation |
Mouse |
RNAi: Atg5, Beclin1 3-methyladenin |
Decrease |
Bax–/–Bak–/– MEF |
Etoposide/staurosporine-induced cell death |
|
Chloroquine |
Decrease |
Neurons |
Autophagic plus partially apoptotic cell death |
|
Fibroblast growth factor (withdrawal) |
Increase |
Neuronal |
Autophagic cell death |
Rat |
Nerve growth factor (withdrawal) |
Increase |
Neurons |
Autophagic/apoptotic death |
|
Serum deprivation |
Increase |
Pheochromocytoma |
Autophagic cell death cathepsin D B |
|
N-meth-D-aspartate |
Increase |
Neurons |
Autophagic cell death |
Human |
RNAi: Atg7, Beclin1 |
Decrease |
Fibroblasts monocytes |
z-VAD–induced cell death |
|
RNA: Atg5, 10, 12 Beclin-1, Vps34 |
Decrease |
HeLa cells |
Apoptotic cell death |
|
RNAi:LAMP2 pH Neutralizers |
Decrease |
HeLa cells |
Apoptotic cell death |
|
Bafilomycin |
Decrease |
Glioblastoma |
Toxic-induced cell death |
|
3-MA Antiestrogen |
Decrease Increase |
Breast cancer |
Irradiation or tamoxifen-induced cell death |
|
ceramide |
Increase |
Glioma cells |
Autophagic and apoptotic cell death |
AUTOPHAGY – THE LIAISON BETWEEN THE LYSOSOMAL SYSTEM AND CELL DEATH |
69 |
capability of autophagy to maintain a positive cellular energy balance is particularly important during nutrient deficiency. Degradation of proteins and even intracellular lipid storages by autophagosomes generates amino acids and free fatty acids that can be used for de novo protein synthesis to support other metabolic pathways such as tricarboxylic acid cycle or to fuel mitochondrial adenosine triphosphate energy production through β-oxidation. This function of autophagy in recycling underlies the ability of this pathway to sustain life during starvation.
This role of autophagy in maintaining cellular bioenergetics has recently proven essential in conditions other than starvation. Thus autophagy is also activated in response to growth factor deprivation or during hypoxia. The rapid degradation of the glucose transporter that follows growth factor withdrawal leaves cells in a compromised energetic balance, but this is prevented by activation of autophagy, which can maintain intracellular ATP levels compatible with cell survival for several weeks.
As described in the previous section, the ability of autophagy to remove defective intracellular components also has a protective effect against cell death. Removal of toxic forms of proteins by autophagy is essential for neuronal survival in various neurodegenerative disorders. Regarding organelles, mitochondria have been the organelle most extensively analyzed given their critical role in cell death pathway. Both the cell death observed on blockage of basal or inducible autophagy depends on mitochondrial outer membrane permeabilization and subsequent caspase activation. However, recent studies support that timely removal of other compromised organelles by autophagy is also essential in preventing cell death. Thus activation of autophagy is often part of the response to endoplasmic reticulum (ER) stress, and failure to activate autophagy under these conditions precipitates cell death both in yeast and in mammalian cells. The high capability of the autophagic systems may be advantageous in certain conditions for the degradation of the compromised ER when compared with the proteasome-mediated degradation of misfolded ER proteins.
Although activation of autophagy has been observed in multiple cellular conditions and in response to numerous stressors, the most convincing evidence of the prosurvival role of this pathway has resulted from genetic studies. Blockage of autophagosome formation in many of those conditions precipitates cell death, supporting thus that the observed activation of autophagy is a cellular survival strategy.
3.2. Autophagy as a cell death mechanism
Autophagic cell death has been historically defined by morphological criteria, namely presence of structures compatible with autophagosomes in a dying cell. However, in recent years it has become clear that the mere presence of autophagosomes is insufficient to distinguish cell death with autophagy from cell death by autophagy. In that respect, the most convincing way to show active participation of autophagy in cell death in a given situation is to demonstrate that blockage of autophagy by manipulation of essential autophagic genes prevents cell death. In fact, multiple reports have now shown decreased apoptosis on inhibition of autophagy under different conditions. For example, silencing of Atg7 or Beclin-1 inhibits the autophagic cell death of L929 cells induced by the pancaspase inhibitor Z-VAD-fmk (N-benzyloxycarbonyl- Val-Ala-Asp- fluoromethylketone). Similarly, embryonic fibroblasts derived from mice that lack the function of the Bcl-2 family member (Bax−/–Bak−/– MEF) are resistant to apoptosis (by treatment with etoposide) but die by autophagic cell death that requires Atg5 and Atg6 function.
However, as a note of caution, a beneficial prosurvival effect of blockage of autophagy can be misleading under certain conditions. Thus, for example, during autophagic stress resulting from the inability of lysosomes to clear autophagosomes, a decrease in autophagosome formation may give the cells a temporary “break.” Massive accumulation of autophagosomes inside cells, as the one observed in some neurodegenerative disorders or in some vacuolar myopathies, results in major alterations in cellular trafficking, energetic dysbalance, and often compromised stability of the autophagosome, with the consequent cytosolic leakage of undegraded toxic cellular products. Under these conditions, knockdown of the genes involved in autophagosome formation will reduce the total autophagosome content and may give time to the lysosomal system to accommodate the clearance of the remaining autophagosomes, with the consequent beneficial effect for the cell. Often, in these circumstances, the original upregulation of the autophagic system was part of the cellular defense against intraor extracellular stressors, and consequently, it should not be classified as cellular death by autophagy, because it is the failure to perform a complete degradative autophagy that leads to compromised cell viability. Different authors have proposed the more appropriate term cell death with autophagy to refer to these conditions. One additional variation on this theme has been